170 related articles for article (PubMed ID: 36389268)
1. Prospective multiparametric CMR characterization and MicroRNA profiling of anthracycline cardiotoxicity: A pilot translational study.
Harries I; Biglino G; Ford K; Nelson M; Rego G; Srivastava P; Williams M; Berlot B; De Garate E; Baritussio A; Liang K; Baquedano M; Chavda N; Lawton C; Shearn A; Otton S; Lowry L; Nightingale AK; Carlos Plana J; Marks D; Emmanueli C; Bucciarelli-Ducci C
Int J Cardiol Heart Vasc; 2022 Dec; 43():101134. PubMed ID: 36389268
[TBL] [Abstract][Full Text] [Related]
2. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular magnetic resonance characterisation of anthracycline cardiotoxicity in adults with normal left ventricular ejection fraction.
Harries I; Berlot B; Ffrench-Constant N; Williams M; Liang K; De Garate E; Baritussio A; Biglino G; Plana JC; Bucciarelli-Ducci C
Int J Cardiol; 2021 Nov; 343():180-186. PubMed ID: 34454967
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer.
Thavendiranathan P; Shalmon T; Fan CS; Houbois C; Amir E; Thevakumaran Y; Somerset E; Malowany JM; Urzua-Fresno C; Yip P; McIntosh C; Sussman MS; Brezden-Masley C; Yan AT; Koch CA; Spiller N; Abdel-Qadir H; Power C; Hanneman K; Wintersperger BJ
JAMA Cardiol; 2023 Jun; 8(6):524-534. PubMed ID: 37043251
[TBL] [Abstract][Full Text] [Related]
5. Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy.
Muehlberg F; Kornfeld M; Zange L; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J
ESC Heart Fail; 2023 Feb; 10(1):616-627. PubMed ID: 36404640
[TBL] [Abstract][Full Text] [Related]
6. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
[TBL] [Abstract][Full Text] [Related]
7. Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement.
Urmeneta Ulloa J; Martínez de Vega V; Salvador Montañés O; Álvarez Vázquez A; Sánchez-Enrique C; Hernández Jiménez S; Sancho García FD; López Ruiz L; Recio Rodríguez M; Pizarro G; Carnevali Ruiz D; Ángel Cabrera J
Int J Cardiol Heart Vasc; 2021 Oct; 36():100854. PubMed ID: 34368419
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular magnetic resonance-based predictors of complete left ventricular systolic functional recovery after rhythm restoration in patients with atrial tachyarrhythmia.
Stegmann C; Jahnke C; Lindemann F; Oebel S; Richter S; Bollmann A; Dagres N; Hindricks G; Paetsch I
Europace; 2022 Jan; 24(1):12-19. PubMed ID: 34279613
[TBL] [Abstract][Full Text] [Related]
11. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
Drafts BC; Twomley KM; D'Agostino R; Lawrence J; Avis N; Ellis LR; Thohan V; Jordan J; Melin SA; Torti FM; Little WC; Hamilton CA; Hundley WG
JACC Cardiovasc Imaging; 2013 Aug; 6(8):877-85. PubMed ID: 23643285
[TBL] [Abstract][Full Text] [Related]
12. Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy-related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT.
Tahir E; Azar M; Shihada S; Seiffert K; Goy Y; Beitzen-Heineke A; Molwitz I; Muellerleile K; Stehning C; Schön G; Adam G; Petersen C; Müller V; Lund GK
Eur Radiol; 2022 Mar; 32(3):1853-1865. PubMed ID: 34536111
[TBL] [Abstract][Full Text] [Related]
13. A Pilot Study of Cardiac MRI in Breast Cancer Survivors After Cardiotoxic Chemotherapy and Three-Dimensional Conformal Radiotherapy.
Bergom C; Rubenstein J; Wilson JF; Welsh A; Ibrahim EH; Prior P; Schottstaedt AM; Eastwood D; Zhang MJ; Currey A; Puckett L; Strande JL; Bradley JA; White J
Front Oncol; 2020; 10():506739. PubMed ID: 33178571
[TBL] [Abstract][Full Text] [Related]
14. Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction.
Lin L; Xie Q; Zheng M; Zhou X; Dekkers IA; Tao Q; Lamb HJ
Eur Radiol; 2021 Sep; 31(9):7098-7109. PubMed ID: 33629157
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
[TBL] [Abstract][Full Text] [Related]
16. Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography.
Zhao R; Shu F; Zhang C; Song F; Xu Y; Guo Y; Xue K; Lin J; Shu X; Hsi DH; Cheng L
JACC CardioOncol; 2020 Mar; 2(1):13-22. PubMed ID: 34396205
[TBL] [Abstract][Full Text] [Related]
17. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.
Gong IY; Ong G; Brezden-Masley C; Dhir V; Deva DP; Chan KKW; Graham JJ; Chow CM; Thavendiranathan P; Dai D; Ng MY; Barfett JJ; Connelly KA; Yan AT
Int J Cardiovasc Imaging; 2019 Apr; 35(4):653-662. PubMed ID: 30390170
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of cardiac magnetic resonance-derived parameters on the improvement of left ventricular function in patients with acute viral myocarditis].
Ouyang HC; Ouyang FC; Mai LL; Chen YY; Hu YZ; Chen HX; Li WS
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Sep; 45(9):758-764. PubMed ID: 29036973
[No Abstract] [Full Text] [Related]
19. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity.
Galán-Arriola C; Lobo M; Vílchez-Tschischke JP; López GJ; de Molina-Iracheta A; Pérez-Martínez C; Agüero J; Fernández-Jiménez R; Martín-García A; Oliver E; Villena-Gutierrez R; Pizarro G; Sánchez PL; Fuster V; Sánchez-González J; Ibanez B
J Am Coll Cardiol; 2019 Feb; 73(7):779-791. PubMed ID: 30784671
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
Higgins AY; Arbune A; Soufer A; Ragheb E; Kwan JM; Lamy J; Henry M; Cuomo JR; Charifa A; Gallegos C; Hull S; Coviello JS; Bader AS; Peters DC; Huber S; Mojibian HR; Sinusas AJ; Kluger H; Baldassarre LA
PLoS One; 2021; 16(2):e0246764. PubMed ID: 33606757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
